Wells Fargo Initiates Coverage on Allscripts-Misys
According to Wells analyst AllScripts (MDRX) has a growth potential of 30% yr/yr over the next 5 years. That would translate to a stock valuation of $25-26 per share.
According to Wells analyst AllScripts (MDRX) has a growth potential of 30% yr/yr over the next 5 years. That would translate to a stock valuation of $25-26 per share.
On September 29, 2009 CNBC Fast Money had a conversation with Allscripts CEO Glenn Tullman
http://www.cnbc.com/id/33076994/site/14081545
According to Mr. Tullman, AllScripts has about 20% of the EHR market, a $4 Billion sector that gets $38 Billion injected as part of Federal government stimulus package, and 70% of that by over the next 3 years!!!
It is always good to see the market size in context of potential prospects.
According to Allscripts CEO, Glenn Tullman, there are 163,000 small-sized physician offices in the US, those with between one and three doctors.
Here is a summary of Mr. Tullman’s interview with CNBC: